Conclusion
Diabetes appears to be a common morbidity in patients affected by
COVID-19 however, the evidence that it increases the risk of infection
is not yet clear. On the other hand, the evidence that diabetes
increases the risk of severe disease and risk of adverse outcomes is
substantial. Patients with diabetes who are at risk of COVID-19 tend to
be obese, of older age, have uncontrolled diabetes and comorbidities, in
particular cardiovascular disease and hypertension. Further research is
still required to investigate appropriate management of people with
diabetes and COVID-19 and develop novel ways of management including
telecare.